JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FORTNER, C. L.
Right arrow Articles by WOODBURY, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FORTNER, C. L.
Right arrow Articles by WOODBURY, R. A.
Journal of Pharmacology And Experimental Therapeutics, Vol. 165, Issue 2, 258-266, 1969
Copyright © 1969 by American Society for Pharmacology and Experimental Therapeutics


EFFECTS OF SYNTHETIC OXYTOCIN WITH AND WITHOUT PRESERVATIVES UPON CORONARY BLOOD FLOW IN THE DOG

CLARENCE L. FORTNER 1, EMMETT S. MANLEY JR. 1, and ROBERT A. WOODBURY 1

1 Department of Pharmacology, University of Tennessee Medical Units, Memphis, Tennessee

These studies include evaluation in anesthetized dogs of the effects of preservative-free synthetic oxytocin, of the commercial preparation of synthetic oxytocin with ethanol and chlorobutanol as preservatives (Syntocinon) and of a synthetic oxytocin-chlorobutanol mixture. Also, the effects of the preservatives, ethanol and chiorobutanol, were investigated separately and in combination. Parameters recorded included phasic coronary blood flow, mean coronary blood flow, myocardial contractile force, heart rate and coronary perfusion pressure. Oxytocin alone in the dog directly constricted the coronary vasculature without modifying other cardiovascular parameters. A biphasic flow response was observed when the commercial preparation was administered. Also, when pure oxytocin was mixed with chlorobutanol, the preparation elicited a biphasic response essentially identical with that seen with the commercial preparation. The preservatives, when administered individually and in combination, were without effect on coronary blood flow. These findings indicate that preservative-free synthetic oxytocin is a coronary vasoconstrictor in the dog and suggest that an interaction occurs between oxytocin and chlorobutanol, the product of which produces a transient increase in coronary blood flow followed by a more prolonged decrease in flow.

Submitted on July 3, 1968
Accepted on October 10, 1968







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics.